Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels

Details for Australian Patent Application No. 2006337617 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Smith-Swintowsky, Virginia L.; Reitz, Allen B.

Agent Shelston IP

Pub. Number AU-A-2006337617

PCT Pub. Number WO2007/092086

Priority 60/751,677 19.12.05 US; 11/611,961 18.12.06 US

Filing date 19 December 2006

Wipo publication date 16 August 2007

International Classifications

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/353 (2006.01)

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/092086 Priority application(s): WO2007/092086

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006337626-[4-(benzo [b] thiophen-2-yl) pyrimidin2yl] -amine derivatives as IKK-beta inhibitors for the treatment of cancer and inflammatory diseases.

2006337614-Wellbore method and apparatus for completion, production and injection